What question did this study set out to answer?

This research aims to understand the molecular implications of HBV integration in hepatocellular carcinoma (HCC).

April 22, 2015PLoS ONEOpen Access

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial identifies hbv-ml4 integration impacting hcc tumors in chinese patients, suggesting a new molecular target.

This research aims to understand the molecular implications of HBV integration in hepatocellular carcinoma (HCC).
Performed whole transcriptome sequencing and genome copy number profiling of 50 HCC samples from Chinese patients.
Identified 33 HBV-human integration sites in 16 out of 44 HBV-positive HCC tissues.
Characterized HBV-MLL4 integration through long-range PCR and Sanger sequencing.
HBV-MLL4 integration was found in 18% (8/44) of the HCC cases among the studied cohort.
MSLL4 was significantly over-expressed due to HBV integration into its exons, with higher mRNA levels compared to integrations in introns.
The integration occurred predominantly in wild-type CTNNB1 and TP53 patients, associated with a distinct gene expression profile.

Dong et al. (2015) studied this question.

View Full Paper

Ask AI

Bookmark